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Abstract: In order to investigate efficacy of praziquantel (biltricide) on morbidity related
to Schistosoma haematobium infection, 300 subjects of which 219 had eggs in the urine were
examined for urinary eggs, blood and protein before and three months after treatment.
Haematuria and proteinuria disappeared in 80.4% and 75.5% of the studied subjects respec-
tively. The disappearance rates were not related to pre-treatment levels of haematuria and
proteinuria. The rates both for haematuria and proteinuria were significantly lower in the
age group 15 years and over than in the younger age group. Parasitologically, praziquantel
cured 85.3% of the egg positives and reduced the mean egg count by 98.2%.
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INTRODUCTION
The infection of Schistosoma haematobium causes variety of pathological changes in the
urinary system, some of which are polypoid lesions, ulcer, calcification of the bladder,
deformity of the ureter. The changes may be found even among very young children of three
years (Forsyth and Bradley, 1966), and the consequences must be serious if patients are le允
untreated for years. A significant mortality related to urinary schistosomiasis was reported
(Forsyth and Bradley, 1966; Smith et al, 1974; Wilkins et al., 1985). The transmissinn nf仙p
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disease continues as long as parasite eggs are excreted into snail habitats. Therefore, a ra-
tional chemotherapy should aim to cure the sick individuals, and to reduce egg excretion at a
community level. An evaluation study of any anti-schistosomal drug should be based on these
two points.
praziquantel has been shown to be a very potent drug against S. haematobium. Many
workers have reported high parasitological cure rate and egg reduction. However, population-
based studies on the effects on morbidity are limited (Mott et al, 1985). With a purpose of in-
vestigation clinical effects of praziquantel, we examined 300 subjects for urinary eggs, blood
and protein, before and three months after treatment with praziquantel in a Kenyan commum-
ty with a moderate infection.
MATERIALS AND METHODS
A total of 915 people were examined for urinary blood and protein using Uro-Labstix
H (MILES-SANKYO CO. LTD.) This type of reagent strip could also test glucose and pH
but these parameters were however not considered in this study since they did not have
direct effect in diagnosis of the infection. Examination of S. haematobium egg was ac-
complished by nuclepore membrane filtration method in the months of June and July. Treat-
ment with praziquantel as a single dose of 40mg/kg body weight was done in July and
August to all egg-positive persons found in the June and July servey and egg-negative per-
sons of age 5 to 15 years.
Three months later, urine examination was repeated and covered 635 people. The data
presented in this paper is for 300 s叫ects of all ages who attended both血しe examination
before and after treatment.
Egg counts per 10 ml of urine was obtained from single random urine specimens ex-
creted between 10.30 and 12.30 hours.
Haematuria and proteinuria were graded as -, -/+, 1+, 2+, 3+.
Haematuria -/+ up and proteinuria 1+ up were regarded as pathological and their
lower levels as normal. Calculation of disappearance rates of haematuria and proteimina was
based on these criteria. For mean egg count, geometric mean of egg counts was used. To
compare cure rates, chi-square test was used, and to compare reduction in egg count pre-
and post-treatment by sex and age group, t-test was used.
RESULTS
Effects of praziquantel on egg excretion
A total of 300 persons analysed consisted of 130 males and 168 females (data by sex
for two individual was not available). In this group, 101 males and 116 females were egg
positive. Data by age included 184 children of 0-14 years, and 115 persons who were 15
years and above (data by age for one person was not available). A hundred and thi吋one
persons of 0-14 years and 87 individuals in the higher age group were egg positive.
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On average, the number of egg-j一ositive persons reduced by 85.3% and there was no
difference by sex and age group. The mean egg count reduced by 98.2% on the average. A
significant di触rence (p<0.001) was found between subjects below 14 years and above 15
years age groups, though the difference in % reduction was very small (99.0 vs. 95.6, Table
u
Changes in egg counts before and after treatment are set out in Table 2. The rate of
moderate- to high-count positives reduced from 71.7% before treatment to 3.2% after treat-
ment. Cure rate of the egg positive cases increased as urinary egg excretion decreased
(p<0.005). Only 3 out of 81 origial negatives (3.7%) turned positive after treatment.
Effects on haematuria and proteinuria
Changes in levels of haematuria before and after treatment are shown in Table 3. In
Table 1. Effects of praziquantel in reducing the number of egg-
positive persons and mean egg count three months after
treatment





































: Geometric mean of (egg count + 1) was calculated to include the
egg negatives after treatment.
: Two persons with unknown sex and one with unknown age are
excluded.
86
those cases with a pre-treatment haematuria of -/+ or up, the disappearance rate of
haematuria was 80.4%. This rate of disappearance was irrespective of pre-treatment levels.
1
In heavy haematuria cases (2+ up) haematuria decreased from 52.3% before treatment to
6.5% after treatment. Twelve cases or 8.2% of the original 147 haematuria negative cases
turned -/+ or up after treatment.
In table 4, changes in levels of proteinuria before and after treatment are shown.
Among the subjects with 1 + up before treatment, the disappearance rate was 75.0%. No dif-
ference was found in between 1+ and 2+ levels of pre-treatment proteinuria. Rate of heavy
proteinuria (2+ up) decreased from 33.1% to 3.2% after treatment. Twenty five or 14.2% of
the 176 original proteinuria negative cases turned 1+ up after treatment.
Table 5. shows the rate of disappearance of haematuria and proteinuria compared by
sex and age group. After praziquantel administration no differences in the disappearance rate
Table 2. Change of egg counts before and three months after treatment with praziquantel
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( ) : percentage of the total at each level of pre-treatment egg count.
{　} : percentage of the grand total (300).




































































( ) : percentage of the total at each level of haematuria.
{　} : percentage of the grand total (300).
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Table 4. Change of levels of proteinuria before and three months after treatment with praziquantel
Pre-treatment proteinuria































{58. 7}　　　　{27. 7}　　　　{13. 7}
300
{100}
negative: Proteinuria - and -/+ are combined.
( ) : Percentage of the total at each level of proteinuria.
{　} : Percentage of the grand total.
Table 5. Comparison of disappearance rates in haematuria and proteinuria after treatment with prazi･
quantel according to sex and age group
Sex Age group
















…: Difference significant at l% level
Difference significant at 5% level.
Two persons with unknown sex and one with unknown age are excluded.
of haematuria and proteinuria was noted between sex. When compared by age there was a
significant difference of haematuria between the older age group (15 years & over) and the
younger group (14 years & below) (p<0.01) with the older group showing 64.7% as com-
pared to 88.1% in the younger age group. Proteinuria disappeared in 75.0% of the studied
subjects. Again, a significant difference was found by age group, with older age group show-
mg 60.5% compared to 81.2% of the younger age (p<o.o5).
DISCUSSION
The present study confirmed the efficacy of praziquantel on parasitological indices, that
is, very high cure rate (85.39及b) and egg reduction rate (98.79及b), in a Kenyan community three
months a触r treatment. However, there was no difference in cure rate between the young
and older age groups in their pre-treatment averages of egg count. Both sexes had similar
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cure rate. The percentage reduction in egg count was found to be very high (98.79及b). No dif-
ference was noted between sex or age. These findings are largely in accordance with the
past data (Davis et al, 1979; McMahon and Kolstrup, 1979; Ejezie and Okeke, 1987),
although much lower cure rates were reported by some authors (Pugh and Teesdale, 1983;
wilkins and Moore, 1987).
Haematuria and proteinuria disappeared in 80.4% and 75.0% of subjects after treat-
ment respectively. The disappearance was not related to pretreatment levels oi! urinary blood
and protein, or sex. However, the disappearance rates both in haematuria and protemuna
were significantly lower in the older age group than in the 0-4 years group. In a similar
study by Mott et al, (1985), haematuria and proteinuria by reagent strips disappeared respec-
tively in 65-73% and 69-72% of subjects after treatment, and the rates of improvement
were similar in all pre-treatment age group. Haematuria was found to be associated strongly
with hyperaemia and ulcer of the urinary bladder (Abdel-Salam and Ehsan 1978). Different
stages of ulcers of the bladder (Lichtenberg, et al, 1971) and urolithiasis will also cause
haematuria. Urinary protein was reported to be of postrenal origin (Doehring et al, 1985),
but the kidney might be also involved (Edington et al, 1970; Lehman et al, 1970; Greenham
and Cameron, 1980). Direct relationship between severity of pathology and intensity of infec-
tion was shown (Forsyth and McDonald, 1965; Lichtenberg et al, 1971, Abdel-Salam a符d
Ehsan, 1978; Warren et al, 1979). The disappearance or reduction in urinary blood and pro-
tein, together with the marked reduction of egg counts, following praziquantel treatment in-
dicate overall improvement of the pathological changes. Several ra舶ological and
ultrasonographical studies which showed rapid disappearance of abnormality after treatment
support his findings (Oyediran et al, 1975; Farid et al, 1984; Doehring et al, 1985).
The clinical improvement was particularly good in children with hi|h egg counts when
treated at early stages of the disease (Lehman et al, 1973). On the other hand, these changes
might become irreversible if patients were left untreated for many years (Forsyth and
McDonald, 1966; McDonald et al, 1968). Therefore, treating patients at early stages of
pathological changes must have substantial benefit, and our study血owed praziquantel was
sufficiently effective.
significantly lower rates of disappearance in haematuria and proteinuria in the older
age group were observed in our study. Lehman et al. (1973) reported the linear increase of
obstructive uropathy, bladder calcification, ureterolithiasis and - bladder retention by age.
Lichtenberg et al (1971) observed much higher egg deposition in the bladder tissue in adults
than in children. More irreversible nature of adult pathology seems to be relate to our
results.
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